SEBI Reg. Investment Advisor

Download App

Help Center Subscribe

Recent:

Top Pharma Companies in India by Market Cap

BSE Sensex 77763.91
261.79 (0.34%)

Filter

Top Pharma Companies in India as on Jul-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)
61	Sun Pharmaceutical Industries Ltd.	Q V+ PT	4,56,989 Large Cap	1,904.65 (1.77%)	39.12	5.37	9.87	23.50	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
62	Glaxosmithkline Pharmaceuticals Ltd.	Q V PT	40,535 Mid Cap	2,392.75 (-0.96%)	39.51	17.93	5.49	17.52	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
63	Ajanta Pharma Ltd.	Q V+ PT	41,550 Mid Cap	3,325.75 (-0.54%)	39.56	9.23	13.54	10.92	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
64	Artemis Medicare Services Ltd.	Q V PT	4,122 Small Cap	260.40 (0.48%)	39.66	4.72	10.15	32.48	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
65	Blue Jet Healthcare Ltd.	Q V PT	9,618 Small Cap	554.45 (-2.41%)	39.77	7.25	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
66	Marksans Pharma Ltd.	Q V+ PT	11,964 Small Cap	264 (-1.14%)	40.25	7.32	22.06	32.86	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
67	Sanofi Consumer Healthcare India Ltd.	Q V+ PT	10,662 Small Cap	4,629.45 (-0.02%)	41.35	23.6	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
68	Kwality Pharmaceuticals Ltd.	Q V+ PT	2,777 Small Cap	2,676 (-1.77%)	41.97	8.5	21.70	37.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
69	Suraksha Diagnostic Ltd.	Q V PT	1,425 Small Cap	273.60 (0.85%)	43.9	5.77	9.86	-51.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
70	SMS Pharmaceuticals Ltd.	Q V+ PT	3,948 Small Cap	421.55 (0.97%)	44.63	4.86	13.70	14.47	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
71	Glenmark Pharmaceuticals Ltd.	Q V+ PT	62,362 Mid Cap	2,209.85 (0.68%)	45.48	5.89	4.60	14.41	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
72	Shree Ganesh Remedies Ltd.	Q V PT	865 Small Cap	673.90 (4.90%)	46.4	5.06	13.20	20.49	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
73	Emcure Pharmaceuticals Ltd.	Q V PT	34,846 Small Cap	1,837.10 (-0.94%)	47.99	9.48	13.02	9.98	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
74	Shilpa Medicare Ltd.	Q V+ PT	11,902 Small Cap	608.55 (1.28%)	48.29	4.54	7.22	-12.54	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
75	Morepen Laboratories Ltd.	Q V PT	3,232 Small Cap	58.99 (-1.21%)	49.53	2.63	14.44	19.03	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
76	Jupiter Life Line Hospitals Ltd.	Q V PT	9,539 Small Cap	1,454.85 (0.12%)	49.78	5.93	21.03	54.25	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
77	Narayana Hrudayalaya Ltd.	Q V PT	40,911 Mid Cap	2,001.90 (0.84%)	50.36	8.94	11.88	45.85	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
78	Mankind Pharma Ltd.	Q V PT	1,04,535 Mid Cap	2,531.15 (1.76%)	50.42	6.27	14.65	12.79	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
79	Granules India Ltd.	Q V+ PT	20,645 Small Cap	833.15 (0.80%)	51.12	4.66	5.58	-0.56	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
80	Concord Biotech Ltd.	Q V PT	13,391 Small Cap	1,280.05 (-0.33%)	51.49	6.66	18.56	18.12	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
81	Poly Medicure Ltd.	Q V PT	17,029 Small Cap	1,680.05 (-3.32%)	52.43	5.77	19.91	26.50	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
82	Bajaj Healthcare Ltd.	Q V PT	1,161 Small Cap	344.75 (0.75%)	54.06	2.16	5.76	2.91	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
83	Thyrocare Technologies Ltd.	Q V+ PT	8,832 Small Cap	554.90 (-0.35%)	54.24	15.31	10.88	8.62	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
84	Dr. Lal Pathlabs Ltd.	Q V PT	27,596 Small Cap	1,646.15 (-0.37%)	54.5	11.51	12.18	13.26	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
85	JB Chemicals & Pharmaceuticals Ltd.	Q V+ PT	37,944 Small Cap	2,363.25 (1.93%)	55.22	9.22	15.51	9.89	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
86	Strides Pharma Science Ltd.	Q V+ PT	10,387 Small Cap	1,126.90 (0.07%)	56.52	3.16	4.81	-16.98	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
87	Bliss GVS Pharma Ltd.	Q V+ PT	5,368 Small Cap	506.15 (-3.87%)	57.64	4.88	9.41	4.67	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
88	Rainbow Childrens Medicare Ltd.	Q V PT	14,620 Small Cap	1,439.45 (1.18%)	57.79	8.55	15.91	24.37	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
89	Syngene International Ltd.	Q V+ PT	17,772 Small Cap	440.25 (0.09%)	58.23	3.77	9.45	1.26	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
90	Metropolis Healthcare Ltd.	Q V PT	11,521 Small Cap	555.70 (2.19%)	59.34	7.45	9.22	2.10	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Suven Life Sciences	327.55	9.68%
Shree Ganesh Remed.	673.90	4.90%
Piramal Pharma	175.90	4.58%
Dishman Carbogen Amc	196.60	4.57%
Kopran	194.55	4.07%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
Rubicon Research	1,302.75	-5.22%
IOL Chem & Pharma	143.05	-4.76%
Bliss GVS Pharma	506.15	-3.87%
Poly Medicure	1,680.05	-3.32%
3B Blackbio Dx	1,172.50	-2.92%

News about Top Pharma Companies in India

Jul, 2026

Ajanta Pharma informs about disclosures

Ajanta Pharma has informed that the Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for CTL Trusteeship.

The above information is a part of company’s filings submitted to BSE.

Jul, 2026

Ajanta Pharma informs about disclosure

Ajanta Pharma has informed that the exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 03, 2026 for Aayush Agrawal Trust & Aayush Agrawal.

The above information is a part of company’s filings submitted to BSE.

Jul, 2026

Emcure Pharmaceuticals informs about acquisition

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘LODR Regulations’) and in furtherance to the disclosure made in the Prospectus filed with the Securities Exchange Board of India, during the Initial Public Offer of the Company, Emcure Pharmaceuticals has informed that Marcan Pharmaceuticals Inc., a subsidiary of the Company (‘Marcan’) has on July 02, 2026 (EDT) entered into share purchase agreements with certain shareholders of Mantra Pharma Inc., a step-down subsidiary of the Company (‘Mantra’), to acquire all of Class E Special Shares in the share capital of Mantra. Consequently, Mantra continues to be 100% subsidiary of Marcan. The particulars of the disclosure required under Regulation 30 and Part A of Schedule III of the LODR Regulations are provided in Annexure A, enclosed.

The above information is a part of company’s filings submitted to BSE.

Jul, 2026

Dr. Lal PathLabs informs about newspaper publication

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Dr. Lal PathLabs has attached the copy of newspaper advertisement(s), published in Financial Express and Jansatta on July 02, 2026, intimating about the dispatch of Notice of 32nd Annual General Meeting and Annual Report for FY 2025-26 to the Members of the Company.

The above information is a part of company’s filings submitted to BSE.

Jul, 2026

Ajanta Pharma gets EIR from USFDA for manufacturing facility at Paithan

The cGMP inspection of the Paithan facility was conducted by the USFDA from April 13, 2026 to April 21, 2026

Jul, 2026

Glenmark Pharmaceuticals informs about media release

Glenmark Pharmaceuticals has informed that, Glenmark Specialty S.A, a wholly owned subsidiary of the company (Glenmark) announced the advancement of its multi-country Phase 3 clinical trial for Trastuzumab rezetecan (SHR-A1811), a HER2-targeted antibody drug conjugate (ADC), for patients with platinum-resistant ovarian cancer (PROC). India will serve as the first country in Glenmark’s licensed markets to initiate patient enrollment for the Phase 3 clinical trial, following the approval of Drugs Controller General of India (DCGI). Glenmark also plans to enroll patients in Australia and South Korea, subject to regulatory approvals. The company has attached media release.

The above information is a part of company’s filings submitted to BSE.

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	Suven Life Sciences Ltd.	8,647 Crore
2	KMC Speciality Hospitals (India) Ltd.	2,180 Crore
3	Indoco Remedies Ltd.	2,257 Crore
4	Themis Medicare Ltd.	1,091 Crore
5	Nectar Lifesciences Ltd.	230 Crore
6	Panacea Biotec Ltd.	3,366 Crore
7	Nephrocare Health Services Ltd.	6,745 Crore
8	Solara Active Pharma Sciences Ltd.	2,783 Crore
9	Hikal Ltd.	2,740 Crore
10	Fischer Medical Ventures Ltd.	2,573 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	25,850	54,930	35.39	11.51	24.16	35.71
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,766	1,61,290	74.55	19.23	39.18	29.04
Ajanta Pharma Ltd. (M)	Very Good	3,326	41,550	39.35	9.18	26.59	25.35
Lupin Ltd. (M)	Somewhat Good	2,476	1,13,215	21.23	5.04	12.28	20.83
Zydus Lifesciences Ltd. (M)	Very Good	1,141	1,13,815	22.58	4.38	13.82	20.74

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	1,542	83,293	103
JB Chemicals & Pharmaceuticals Ltd. (S)	Very Good	2,363	37,944	44.17
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,766	1,61,290	42.84
Aurobindo Pharma Ltd. (M)	Very Good	1,620	93,217	40.20
Gland Pharma Ltd. (S)	Very Good	2,461	40,588	31.30
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
JB Chemicals & Pharmaceuticals Ltd. (S)	Very Good	2,363	37,944	56.29	9.40	34.09	15.51
Mankind Pharma Ltd. (M)	Very Good	2,531	1,04,535	51.30	6.38	32.20	14.65
Ajanta Pharma Ltd. (M)	Very Good	3,326	41,550	39.35	9.18	26.59	13.54
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,375	1,14,730	27.34	3.04	15.25	12.09
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,766	1,61,290	74.55	19.23	39.18	11.80

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Zydus Lifesciences Ltd. (M)	Very Good	1,141	1,13,815	22.58	4.38	13.82	30.57
Sun Pharmaceutical Industries Ltd. (L)	Very Good	1,905	4,56,989	39.81	5.47	22.81	23.50
Abbott India Ltd. (M)	Very Good	25,850	54,930	35.39	11.51	24.16	18.78
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,375	1,14,730	27.34	3.04	15.25	15.75
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,210	62,362	45.79	5.93	12.16	14.41

You have 9 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now

Create stable, long-term investment portfolio with strong, consistent stocks.

Start Research-backed Investing ...Now. Subscribe to Sapphire

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Ajanta Pharma informs about disclosures

Ajanta Pharma informs about disclosure

Emcure Pharmaceuticals informs about acquisition

Dr. Lal PathLabs informs about newspaper publication

Ajanta Pharma gets EIR from USFDA for manufacturing facility at Paithan

Glenmark Pharmaceuticals informs about media release

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.